(HealthDay News) -- Antiviral therapy may halt or slow recurrence of liver cancer in patients with chronic hepatitis B and extend their lives, finds a new study.
Previous research has shown that antiviral therapy reduces the incidence of liver cancer in such patients.
This study looked at 15 patients with chronic hepatitis B (CHB) who underwent the local removal of a liver tumor known as a "single hepatocellular carcinoma" (HCC) that was less than four centimeters. HCC is the most common primary malignant tumor of the liver.
Six of the patients were diagnosed between 1991 and 1997, prior to the development of antiviral therapy. They were classified as historical controls.
The other nine were diagnosed between 2000 and 2004 and began ongoing antiviral therapy with lamivudine immediately after HCC diagnosis. In some cases, patients were also prescribed other antiviral medications, such as tenofovir and adefovir. Read more...
Ayurtox for Body Detoxification
Subscribe to:
Post Comments (Atom)
Health Begins In The Colon$19.99  The REAL Secret to Health is Finally Revealed! Did you know that disease starts and health begins in the colon? You can read more about how to better your health in Dr. Group's exclusive book |
No comments:
Post a Comment